Oseltamivir-resistant influenza A(H1N1)pdm09 viruses, United States, 2013-14

Insights

Oseltamivir-resistant influenza A(H1N1)pdm09 viruses were found in the US during 2013-14. Local surveillance is crucial for monitoring neuraminidase inhibitor susceptibility in circulating flu strains.

Area of Science:

  • Virology
  • Infectious Diseases
  • Public Health

Background:

  • Influenza A(H1N1)pdm09 is a significant human pathogen.
  • Neuraminidase inhibitors like oseltamivir are key antiviral treatments.
  • Emergence of drug resistance can impact treatment efficacy.

Purpose of the Study:

  • To characterize oseltamivir-resistant influenza A(H1N1)pdm09 viruses.
  • To describe patients infected with these resistant strains in the US.
  • To highlight the importance of ongoing surveillance for antiviral resistance.

Main Methods:

  • Analysis of influenza virus samples collected in the US during the 2013-14 season.
  • Genomic sequencing to identify specific mutations conferring resistance, such as H275Y.
  • Clinical data collection from infected patients.

Main Results:

  • Fifty-nine (1.2%) of 4,968 analyzed influenza A(H1N1)pdm09 viruses exhibited the H275Y substitution.
  • This substitution confers resistance to oseltamivir.
  • The findings indicate a detectable prevalence of resistance in the US during the study period.

Conclusions:

  • Oseltamivir resistance in influenza A(H1N1)pdm09 is present in the United States.
  • The H275Y mutation is a key marker for oseltamivir resistance.
  • Continuous local surveillance of neuraminidase inhibitor susceptibility is essential for effective influenza management.

Related Concept Videos